Opinion|Videos|August 28, 2024
Early Diagnosis and Treatment for Central Precocious Puberty
The panel explores the impact of early versus delayed diagnosis and treatment initiation on long-term outcomes in Central Precocious Puberty patients.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- How might an early CPP diagnosis and subsequent treatment initiation affect outcomes, compared to a later start?
Advertisement
Related to this article
Nationwide Children's experts urge early screening and family-based lifestyle change as youth-onset T2D progresses faster than adult disease.
Glucommander Pediatrics received FDA Breakthrough Device Designation for IV insulin dosing in hospitalized children younger than 2 years, but remains uncleared.
ISPAD, EASD, and ADA urge pediatric diabetes teams to build center-specific transition policies, use readiness checklists, and ensure timely handoffs to adult clinicians.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Hand, foot, and mouth disease: Red flags pediatricians should know
2
FDA approval of Gazyva offers new option for pediatric INS
3
DTaP 96% effective against pertussis in Alaska outbreak
4
FDA grants Cinainu Breakthrough Therapy status for pediatric AA
5